MRK

#40
Merck & Co., Inc.
119.75 USD
-0.39%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
119.58
119.91
Intervallo Annuale
73.31
125.14
Variazione giornaliera
-0.39%
Variazione Mensile
+3.82%
Variazione di 6 mesi
+41.98%
Variazione Annuale
+50.63%
Chiusura Precedente
120.22
Apertura
119.58
Bid
Ask
Minimo
119.58
High
119.91
Volume
2 279
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 296.07 B
  • Employee 75 K
  • Founded N/A
  • CEO Robert M Davis
  • Website www.merck.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BPD168
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
14.46
Rapporto prezzo/fatturato
4.06
Dividendi per azione
3.28
Rendimento da dividendi %
3.12

Merck & Company Inc (new)

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

Notizie